| Literature DB >> 33980214 |
Veronika Yehezkeli1,2, Ygal Rotenstreich2,3, Liron Naftali Ben Haim1,2, Ifat Sher2,3, Asaf Achiron2,4, Avner Belkin5,6.
Abstract
BACKGROUND: The goal of this study is to compare ophthalmic emergency room (OER) visits during the Coronavirus disease-19 (Covid-19) pandemic to those during a control period.Entities:
Keywords: Comparisons; Covid − 19; ER; Ophthalmic emergency; Visits
Mesh:
Year: 2021 PMID: 33980214 PMCID: PMC8114655 DOI: 10.1186/s12886-021-01976-6
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Demographic characteristics of study participants
| Variable | March–April | March–April | |
|---|---|---|---|
| Number of eyes | 834 | 477 | |
Age, years mean (SD) | 48.8 (21.36) | 48.1 (20.1) | |
Male n (%)a | 467 (56%) | 289 (60.58%) | |
Ethnicity n (%) | |||
| Jewish | 694 (83.2%) | 397 (83.2%) | |
| Arab | 130 (15.5%) | 75 (15.7%) | |
| Otherb | 10 (1.1%) | 5 (1%) | |
| Distance from hospital, Km | |||
| Mean (SD) | 14.8 (16.7) | 19.2 (26.3) | |
| Median (IQR) | 11.9 (17.3) | 13.5 (16.9) | |
Abbreviations: IQR interquartile range, SD standard deviation, Km kilometer. a Percentage calculated from total visits
bForeign workers from China, Nepal, Thailand; Tourists from Europe
Fig. 1The distribution of patients by age; Inner circle 2019, outer circle 2020. No statistical difference was found between the age groups
Fig. 2The time of day patients arrived at the emergency department; Inner circle 2019, outer circle 2020. Patients were more likely to arrive in the morning hours (6 AM-12 PM) in 2020 (P = 0.002*)
Visit characteristics
| Variable | March–April | March–April | |
|---|---|---|---|
Referral n (%) | |||
| Optometrist | 1 (0.12%) | 0 (0%) | |
| Primary care ophthalmologist | 111 (13.3%) | 63 (13.2%) | |
| Primary care non-ophthalmologist | 232 (27.8%) | 98 (20.5%) | |
| In hospital consult | 68 (8.1%) | 26 (5.4%) | |
| Self-referral | 381 (45.7%) | 196 (41.1%) | |
| Follow up to prior visit at our clinic | 41 (4.9%) | 94 (19.7%) | |
Trauma n (%) | |||
| No trauma | 676 (81%) | 405 (85%) | |
| Indoor trauma | 52 (6.2%) | 15 (3.1%) | |
| Outdoor trauma | 106 (12.7%) | 56 (11.7%) | |
| Eye n (%) | |||
| OD/OS | 701 (85.5%) | 420 (88.2%) | |
| OU | 119 (14.5%) | 56 (11.7%) | |
Complaint duration, days mean (SD) | 3.9 (7.8) | 4.5 (7.8) | |
Chief complaint n (%) | |||
| Reduction in vision monocular | 83 (9.9%) | 77 (16.1%) | |
| Reduction in vision binocular | 18 (2.2%) | 8 (1.7%) | |
| Diplopia | 13 (1.6%) | 2 (0.4%) | |
| Floater | 87 (10.4%) | 26 (5.4%) | |
| Other visual disturbancea | 18 (2.1%) | 27 (5.6%) | |
| Lid related | 64 (7.7%) | 23 (4.8%) | |
| Ocular pain monocular | 395 (47%) | 228 (47.8%) | |
| Ocular pain binocular | 46 (5.52%) | 18 (3.8%) | |
| Red eye | 71 (8.5%) | 31 (6.5%) | |
| Otherb | 56 (7%) | 52 (11%) | |
Abbreviations SD standard deviation
aMetamorphopsia, “Clouds”, black bubbles, flashes of light
bAsymptomatic patients who were referred by other physicians to r/o papilledema, uveitis, high IOP, suspected Neovascular Age related Macular Degeneration, suspected Branch retinal vein occlusion and new rubeosis iridis
Ophthalmologic examination and clinical findings
| Variable | March–April | March–April | |
|---|---|---|---|
LogMar VA mean (SD) | |||
| CC eye | 0.34 (0.5) | 0.42 (0.6) | |
| Fellow eye | 0.26 (0.4) | 0.23 (0.4) | |
IOP, mmHg mean (SD) | |||
| OD | 13.94 (4.6) | 14.8 (5.7) | |
| OS | 14.14 (4) | 13.96 (5.9) | |
Eye segment involved n (%) | |||
| Anterior chamber | 572 (68.6%) | 319 (66.9%) | |
| Posterior segment | 159 (19%) | 91 (19%) | |
| Both | 10 (1.2%) | 23 (4.8%) | |
| Nonea | 93 (11.1%) | 43 (9%) | |
Main clinical finding n (%) | |||
| Normal examination | 85 (10.2%) | 45 (9.4%) | |
| Foreign body | 108 (12.9%) | 74 (15.5%) | |
| Conjunctivitis | 72 (8.6%) | 24 (5%) | |
| Retinal Vascular eventb | 11 (1.3%) | 9 (1.9%) | |
| Retinal tear | 24 (2.9%) | 13 (2.7%) | |
| Retinal Detachment | 10 (1.1%) | 8 (1.7%) | |
| Perforation | 3 (0.3%) | 0 | |
| Neuro ophthalmology | 19 (2.3%)c | 16 (3.3%)d | |
| Anterior segment inflammation | 23 (2.7%) | 14 (2.9%)_ | |
| Posterior segment inflammation | 1 (0.1%) | 0 | |
| Glaucoma (open and closed angle) | 12 (1.4%) | 19 (4%) | |
| Dry eye | 37 (4.4%) | 17 (3.6%) | |
| Corneal laceration | 85 (10.2%) | 54 (11.3%) | |
| Conjunctival laceration | 13 (1.5%) | 8 (1.7%) | |
| SPK | 66 (7.9%) | 30 (6.3%) | |
| Chalazion | 14 (1.7%) | 9 (1.9%) | |
| PVD | 62 (7.4%) | 21 (4.4%) | |
| Lid swelling | 43 (5.1%) | 22 (4.6%) | |
| SCH | 31 (3.7%) | 14 (2.9%) | |
| Corneal abscess | 36 (4.3%) | 40 (8.4%) | |
| Blepharitis | 21 (2.5%) | 6 (1.2%) | |
| Retinopathye | 10 (1.2%) | 10 (2.1%) | |
| VH | 14 (1.7%) | 13 (2.7%) | |
| Otherf | 59 (7.1%) | 58 (12.1%) | |
Number of diagnoses mean (SD) | 0.93 (0.35) | 1.0 (0.5) | |
One diagnosis n (%) | 724 (86.8%) | 388 (81.3%) | |
Two diagnoses and more n (%) | 25 (3%) | 43 (9%) | |
Abbreviations: SPK superficial punctate keratitis, PVD posterior vitreous detachment, SCH subconjunctival hemorrhage, VH vitreous hemorrhage, SD standard deviation
aEyelids related or neuro-ophthalmologic complains which didn’t refer to eye segments (i.e. visual migraine, nerve palsies, etc. …)
bArterial occlusions and Vein occlusions
c6th nerve palsy (3), 3rd nerve palsy (2), Anterior ischemic optic neuropathy (AION) (2), Optic neuritis (ON) (2), visual migraine (3), anisocoria (1), benign cyclic mydriasis (1), papilledema (5)
d6th nerve palsy (3), ON (7), papilledema (2), bell’s palsy (1), compressive optic neuropathy (1), optic atrophy (1), 3rd nerve palsy (1)
eDiabetic retinopathy / hypertensive retinopathy / high-altitude retinopathy
fNeovascular age related macular degeneration, corneal graft rejection, choroidal neovascularization, lattice degeneration, corneal opacity, subluxation of the lens, commotio retina, hyphema, dacryocystitis
Case Management
| Variable | March–April | March–April | |
|---|---|---|---|
Treatment n (%) | |||
| No treatment | 244 (29.2%) | 104 (23.2%) | |
| Topical antibiotics | 331 (39.7%) | 227 (47.6%) | |
| Topical steroids | 88 (10.5%) | 97 (20.3%) | |
| Lubrication | 187 (22.2%) | 143 (30%) | |
| Systemic antibiotics | 47 (5.6%) | 22 (4.6%) | |
| Systemic steroids | 4 (0.47%) | 10 (2.1%) | |
| Intravitreal injections | 19 (2.3%) | 12 (2.5%) | |
| Glaucoma treatment (Topical and systemic) | 14 (1.7%) | 28 (5.9%) | |
| Othera | 12 (1.4%) | 41 (8.6%) | |
Number of treatments mean (SD) | 0.84 (0.67) | 1.22 (0.95) | |
One treatment n (%) | 493 (59.1%) | 221 (46.3%) | |
Two or more treatments n (%) | 97 (11.6%) | 151 (31.6%) | |
Auxiliary tests n (%) | |||
| No Auxiliary tests | 751 (90%) | 388 (81.3%) | |
| OCT | 64 (7.7%) | 62 (12.3%) | |
| Visual fields | 20 (2.4%) | 16 (3.3%) | |
| FA | 6 (0.7%) | 13 (2.7%) | |
| US | 8 (0.9%) | 14 (2.9%) | |
Number of Auxiliary tests mean (SD) | 1.02 (0.16) | 1.06 (0.3) | |
Office procedures n (%) | |||
| No office procedures | 673 (80.7%) | 368 (77.1%) | |
| Foreign body removal cornea | 63 (7.5%) | 58 (12.2%) | |
| Foreign body removal conjunctiva | 47 (5.6%) | 17 (3.6%) | |
| Laser Barrage | 22 (2.6%) | 15 (3.1%) | |
| Eye irrigation | 19 (2.3%) | 6 (1.2%) | |
Hospitalizations n (%) | 28 (3.3%)b | 9 (1.9%)c | |
Follow up location n (%) | |||
| Hospital | 254 (30.4%) | 222 (46.5%) | |
| Outside clinic | 403 (48.3%) | 169 (35.4%) | |
| None | 177 (21.2%) | 85 (17.8%) | |
| Number of emergent surgeries | 15 (1.8%) | 17 (3.7%) | |
Time from diagnosis to surgery, days mean (SD) | 2.86 (1.91) | 2.23 (1.95) | |
| Number of in hospital consults | 16 (1.9%) | 14 (2.9%) | |
Abbreviations: OCT optical coherence tomography, FA fluorescein angiography, US ultrasound, SD standard deviation
aAcyclovir; Anti-allergic treatment (topical and systemic)
b 3rd nerve palsy, optic neuritis (ON) and anisocoria in neurologic department (3), corneal abscess (1), peri-orbital cellulitis (3), high IOP (5), ruptured globe and conjunctival laceration (2), endophthalmitis following anti- VEGF injection, retinal artery occlusion (RAO) and vein occlusion for systemic evaluation (3), evisceration (1), retinal detachment (RD) (3) and thyroid eye disease for systemic steroids (1)
cRAO (1), retinitis (1), RD (1), ON (4), high IOP and VZV with corneal involvement